| Literature DB >> 29791574 |
Natasha Soares Simões Dos Santos1, Andrea de Andrade Vilela1, Rodrigo Bellio de Mattos Barretto1, Marcela Paganelli do Vale1, Mariana Oliveira Rezende1, Murilo Castro Ferreira1, Alexandre José Aguiar Andrade1, Nelson Henrique Goes Scorsioni1, Olívia Ximenes de Queiroga1, David Le Bihan1.
Abstract
BACKGROUND: Unstable angina (UA) is a common cause of hospital admission; risk stratification helps determine strategies for treatment.Entities:
Mesh:
Year: 2018 PMID: 29791574 PMCID: PMC5941958 DOI: 10.5935/abc.20180062
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 1Polar map with coronary irrigation correlation. AD: anterior descending coronary artery; CX: circumflex coronary artery; RD: right coronary artery.
Clinical characteristics of studied population (n = 78)
| Median [p25- 75] | |
|---|---|
| Age (years) | 61,5 [53 - 69] |
|
| |
| Male | 60,3% |
| Female | 39,4% |
| BMI (Kg/m2) | 28,16 [24,47 - 30,71] |
| SBP (mmHg) | 137 [122,75 - 154,25] |
| HR (bpm) | 74 [69 - 83,5] |
| Serum Creatinine (mg/dL) | 0,9 [0,7 - 1,1] |
| GRACE (points) | 95 [81 - 117] |
| Troponin (pg/mL) | 0,02 [0,01 - 0,05] |
| High blood pressure (%) | 88,5% |
| Diabetes (%) | 38,5% |
| Smoking (%) | 32,1% |
| Dyslipidemia (%) | 65,4% |
| Family history for CAD (%) | 19,2% |
| Known CAD (%) | 66,7% |
|
| |
| ACEI | 32,1% |
| ARB | 41% |
| Beta blocker | 65,4% |
| Acetylsalicylic acid | 82,1% |
| Other antiplatelet | 29,5% |
| Calcium channel blocker | 33,3% |
| Statin | 76,9% |
| Nitrate | 37,2% |
|
| |
| Surgical revascularization | 11,5% |
| Angioplasty | 22,1% |
| Angioplasty + Surgical revascularization | 16,7% |
| Previous MI (%) | 56,4% |
BMI: body mass index; SBP: systolic blood pressure; HR: heart rate; CAD: coronary artery disease; AMI: acute myocardial infarction; ACEI: angiotensinogen converting enzyme inhibitor; ARB: angiotensin receptor AT-2 blocker.
Electrocardiographic findings (n = 78)
| Change | Frequency (%) |
|---|---|
| LBBCD | 10,3% |
| RBBB | 3,8% |
| LASDB | 2,6% |
| RBBB + LASDB | 2,6% |
| LBBB | 3,8% |
| Q wave pathological | 3,8% |
| Pacemaker pace | 3,8% |
| High response AF | 1,3% |
| CVR anterosseptal | 5,1% |
| Previous CVR | 5,1% |
| Lower CVR | 9% |
| Side CVR | 7,7% |
| Diffuse CVR | 11,5% |
| Infra/ST > 0,5 mm | 1,3% |
LBBCD: left bundle branch conduction disorder; RBBB: right bundle branch block; LASDB: left anterior superior divisional block; CVR: change in ventricular repolarization; LBBB: left bundle branch block; AF: atrial fibrillation.
Echocardiographic findings (n = 55)
| Variable | Median [p25 - p75] |
|---|---|
| LVEF Simpson | 0,59 [0,5 - 0,65] |
| LA (mm) | 39 [36 - 42] |
| LVFDD (mm) | 51 [48 - 56] |
| LVFSD (mm) | 32 [30 - 37,75] |
| Septum (mm) | 10 [9 - 11] |
| Posterior wall (mm) | 9 [9 - 11] |
| Mass index (g/m2) | 124,5 [110 - 153,5] |
| PASP (mmHg) | 32 [31 - 36] |
| Aorta root (mm) | 34 [31 - 36] |
LVEF: left ventricular ejection fraction; LA: measurement of the left atrium; LVFDD: left ventricle final diastolic diameter; LVFSD: left ventricular final systolic diameter; PASP: pulmonary artery systolic pressure.
Clinical and echocardiographic characteristics of patients undergoing longitudinal strain analysis (group A, n = 15) compared to non-submitted patients (group B, n = 63)
| Group A | Group B | p | |||
|---|---|---|---|---|---|
| Median | Interquartile Interval | Median | Interquartile Interval | ||
| Age (years) | 57 | 16 | 62 | 16 | 0,899 |
|
| |||||
| Male | 33,3% | 66,7% | 0,037 | ||
| Female | 66,7% | 33,3% | |||
| BMI (Kg/m2) | 28,62 | 7,2 | 28,12 | 6,56 | 0,903 |
| SBP (mmHg) | 143 | 33 | 137 | 31 | 0,510 |
| HR (bpm) | 78 | 23 | 74 | 14 | 0,824 |
| Creatinine (mg/dL) | 0,7 | 0,5 | 0,9 | 0,3 | 0,127 |
| GRACE (points) | 94 | 27 | 97 | 36 | 0,287 |
| Hypertension (%) | 80% | 90,5% | 0,363 | ||
| Diabetes (%) | 13,3% | 44,4% | 0,037 | ||
| Smoking (%) | 33,3% | 31,7% | 1 | ||
| Dyslipidemia (%) | 60% | 66,7% | 0,764 | ||
| Family history for CAD (%) | 26,7% | 17,5% | 0,470 | ||
| LVEF Simpson | 0,65 | 0,08 | 0,55 | 0,18 | 0,006 |
| LA (mm) | 37 | 5 | 40 | 9 | 0,009 |
| LVFDD (mm) | 48 | 5 | 53,5 | 9 | 0,007 |
| LVFSD (mm) | 31 | 6 | 37 | 7 | 0,112 |
| Septum (mm) | 10 | 2 | 10 | 3 | 0,668 |
| Posterior wall (mm) | 9 | 1 | 10 | 2 | 0,118 |
| Mass index (g/m2) | 109 | 49 | 133,5 | 26 | 0,095 |
| PASP (mmHg) | 34 | 13 | 29,5 | 10 | 0,895 |
| Aorta root (mm) | 31 | 4 | 35 | 4 | 0,006 |
|
| |||||
| ACEI | 33,3% | 31,7% | 1 | ||
| ARB | 20% | 46% | 0,084 | ||
| Beta blocker | 20% | 76,2% | < 0,001 | ||
| Acetylsalicylic acid | 60% | 87,3% | 0,023 | ||
| Calcium channel blocker | 26,7% | 34,9% | 0,762 | ||
| Statin | 53,3% | 82,5% | 0,035 | ||
| Nitrate | 40% | 36,5% | 1 | ||
BMI: body mass index; SBP: systolic blood pressure; HR: heart rate; LVEF: left ventricular ejection fraction; LA: measurement of the left atrium; LVFDD: left ventricular final diastolic diameter; LVFSD: left ventricular final systolic diameter; PASP: pulmonary artery systolic pressure. ACEI: angiotensinogen converting enzyme inhibitor; ARB: angiotensin receptor AT-2 blocker. Mann-Whitney was used for continuous variables (expressed in median and interquartile range) and Fisher's exact test for categorical variables (expressed as percentage).
Risk score of patients submitted to longitudinal strain analysis
| Score | Frequency (%) |
|---|---|
|
| |
| ≤ 108 points | 86,7% |
| 109-139 points | 13,3% |
| ≥ 140 points | 0% |
GRACE - Low risk - ≤ 108, moderate risk - 109 to 139, ≥ 140 - high risk
Figure 2ROC curve to evaluate ability of global strain to identify severe lesion (> 70%) in any epicardial coronary artery. Area under the ROC curve 0.875, with p < 0.014.
Figure 3Case of patient with unstable angina, anterior descending coronary artery with 90% lesion in the proximal third and circumflex coronary artery with lesion of 70% in the middle third.